Immunofluorescence analysis revealed an increase in cleaved caspase-3 (Cl-Cas3) expression in gracillin-treated breast patient-derived xenograft (PDX) tumors (Figure 4E), indicating a proapoptotic effect of gracillin in breast cancer cells in vivo. This evidence concerns the gene CASP3 and breast cancer.